Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2019-10-09 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
108年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no audit information, no voting results, no legal proceedings, and no mention of any report publication. The document is short (601 characters) and purely informational about financial guarantees and loans, fitting the profile of a regulatory compliance announcement rather than a full report or detailed filing. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory disclosures that do not fit other categories.
2019-10-09 Chinese
108年9月營業收入
Fund Information / Factsheet Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 景岳, with data for the month and year-to-date compared to the previous year. It includes explanations about accounting standards (IFRS) and reporting practices. The document length is short (767 characters) and it primarily provides financial summary data without detailed financial statements or analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It is more of a brief financial summary or factsheet. Given the concise nature and summary format, the best fitting category is Fund Information / Factsheet (FS).
2019-10-09 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (景岳生物科技股份有限公司) regarding its commitments made when applying for stock listing transfer from OTC to main board and the subsequent execution status as of the third quarter of 2019 (108/09/30). It references compliance with a Taiwan Stock Exchange regulation letter and details about auditor commitments and financial reporting. The document is short (768 characters) and primarily serves as a regulatory disclosure of compliance status rather than a full financial report or detailed audit report. It does not contain financial statements or detailed financial analysis. Therefore, it fits best as a Regulatory Filing (RNS) rather than an Annual Report, Audit Report, or Interim Report. It is not a report publication announcement since it contains substantive disclosure, not just a notice of report availability.
2019-10-03 Chinese
108年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 景岳, providing information about fund lending balances and endorsement guarantees for the current and previous months, with all values being zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and lending, without detailed financial statements or analysis. It does not contain any narrative, management discussion, or comprehensive financial data. This type of document is a regulatory disclosure about financial guarantees and fund lending status, typical of a regulatory filing rather than a full report or announcement. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2019-09-09 Chinese
108年8月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 景岳, with data for August 2019 (民國108年08月). It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document is very short (770 characters) and primarily presents financial summary data without detailed financial statements or management discussion. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It also does not fit categories like Earnings Release (ER) because it lacks key highlights or narrative. The document is more of a regulatory or public disclosure summary of financial data, typical of a Regulatory Filing (RNS) in the context of Taiwanese market disclosures. Therefore, the best classification is Regulatory Filings (RNS).
2019-09-09 Chinese
108年08月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company directors and executives. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The document is not a report or announcement of a report but a direct disclosure of insider shareholdings. Therefore, it fits the category of Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just a notice or announcement.
2019-09-04 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.